New guidelines for development and approval of biosimilars move closer
EuropaBio welcomes the direct dialogue and calls upon the EU to settle all outstanding important issues before the first biosimilars enter the market
14-Dec-2005 -
EuropaBio welcomes the initiative of the EMEA to publicly debate and engage in a direct dialogue on the development and approval of similar biological medicinal products (biosimilars). An EMEA/DIA Workshop has offered all stakeholders, including the industry, the opportunity to present comments ...
pharmacovigilance